Cells respond to stress by coordinating proliferative and metabolic pathways. Starvation restricts cell proliferative (glycolytic) and activates energy productive (oxidative) pathways. Conversely, cell growth and proliferation require increased glycolytic and decreased oxidative metabolism levels 1 . E2F transcription factors regulate both proliferative and metabolic genes 2,3 . E2Fs have been implicated in the G1/S cell-cycle transition, DNA repair, apoptosis, development and differentiation 2-4 . In pancreatic β-cells, E2F1 gene regulation facilitated glucose-stimulated insulin secretion 5, 6 . Moreover, mice lacking E2F1 (E2f1 −/− ) were resistant to diet-induced obesity 4 . Here, we show that E2F1 coordinates cellular responses by acting as a regulatory switch between cell proliferation and metabolism. In basal conditions, E2F1 repressed key genes that regulate energy homeostasis and mitochondrial functions in muscle and brown adipose tissue.
), as well as a higher level of mitochondrial enzyme activity ( Supplementary Fig. S1g-i) . E2f1 inactivation resulted in increased thermogenesis and mitochondrial activity, indicating increased oxidative metabolism. Typically, GNM is predominantly glycolytic; thus, in response to succinate and ADP, O 2 consumption was not induced in GNM of E2f1 +/+ mice, but the level was increased in GNM of E2f1 −/− mice (Fig. 1g ). This indicated that the GNMs of E2f1 −/− mice switched to oxidative metabolism. Moreover, in vivo electroporation of E2F1 DNA into the GNM of E2f1 −/− mice caused a reduction of mitochondrial activity (Fig. 1g ). E2F1 expression in electroporated muscles was demonstrated by immunofluorescence microscopy staining ( Supplementary Fig. S1j ). Furthermore, E2f1 −/− GNM showed an increased level of protein and messenger RNA expression of slow-twitch oxidative myofibre genes (MyHC-I, also known as MyH7, myosin, heavy polypeptide 7; and MyHC-IIa, also known as MyH2) and a decreased level of expression of the fast-twitch glycolytic myofibre gene encoding MyHC-IIb (also known as MyH4) when compared with E2f1 +/+ mice ( MyHC-I and -IIa fibres are resistant to fatigue; therefore, we investigated the endurance of weight-matched E2f1 +/+ and E2f1 −/− mice with treadmill running to exhaustion. E2f1 −/− mice ran at least twice the distance (mean = 1,700 m) of E2f1 +/+ mice (mean = 850 m) before exhaustion ( Fig. 1j and Supplementary Fig. S2f ). Moreover, electroporation of E2F1 in E2f1 −/− GNM decreased the running endurance (1,400 m; P < 0.05; Fig. 1k and Supplementary Fig. S2g ). These results mice was evaluated with an endurance test. Individual performances are represented for E2f1 wild-type mice electroporated with empty vector (E2f1 +/+ pCMV), knockout (E2f1 −/− pCMV) and knockout-rescued animals (E2f1 −/− pCMV-E2F1). n = 4 animals for E2f1 +/+ pCMV group; n = 3 animals for E2f1 −/− pCMV group; n = 3 animals for E2f1 −/− pCMV-E2F1 group. Values represent means ± s.e.m. * P < 0.05. * * P < 0.01.
indicated that E2F1 negatively regulated oxidative metabolism, which decreased the level of thermogenesis and physical endurance.
We then analysed the expression of potential E2F1 target genes implicated in mitochondrial function. E2f1 −/− BAT and/or GNM showed increased levels of gene expression in the mitochondrial respiratory chain (Atp5g1, Cox5a, Nduf1c, Sdha and Uqcr), the tricarboxylic acid (TCA) cycle (Idh3a), uncoupling respiration (Ucp1, 2), transcription regulation (Ppargc1a, Esrra and Tfam) and fatty acid oxidation (Acadl, Pdk4 and Cpt-1; Fig. 2a,b and Supplementary  Table S1 ). Interestingly, expression of two classical E2F1 target genes involved in cellular proliferation, Dhfr or Tk1, were unchanged (Fig. 2a,b) . We observed increased mitochondrial DNA content and function ( Supplementary Fig. S3a,b 
) in distinct E2f1
−/− muscles (diaphragm, tibialis) and in other tissues (liver), which was consistent with increased levels of expression of genes involved in mitochondrial activity, as described above ( Supplementary Fig. S3c ). Levels of mitochondrial DNA content, function and oxidative gene expression were also increased in E2f1 −/− mouse embryonic fibroblasts (MEFs; Supplementary Fig. S4a-d) . Together, these results indicated that E2F1 modulated oxidative metabolism in different organs and cell types. Moreover, E2f1 gene inactivation resulted in increased O 2 consumption in diaphragm and liver. Interestingly, this effect was independent of PGC-1α, because expression of this factor was not changed in these tissues in E2f1 −/− mice. 
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Nduf1c Uqcr Idh3a Cox5a Computational analysis of the promoter region of oxidative genes revealed the presence of an E2F binding site in the regulatory sequences of Cox5a, Cpt-1, Pdk4, Ppargc1a, Ucp1, Ucp2, Tfam, Esrra and Sdha (data not shown). In vivo knockdown experiments of these genes by muscle electroporation of short hairpin RNAs (shRNAs) in an E2f1-null background decreased the level of oxygen consumption of mitochondria isolated from GNM (Fig. 2c,d ) or permeabilized MEFs ( Supplementary Fig. S4e,f) . Therefore, the partial rescue of the wild-type phenotype in E2f1 −/− cells by specific shRNAs indicated that each of these genes contributed to the effect of E2F1 on oxidative metabolism.
Under cold and fasting conditions, the oxidative metabolism gene expression level was increased in BAT and muscle (Fig. 3a,b) . We investigated whether E2F1 and pRB (also known as Rb1, retinoblastoma 1) complexes mediated the metabolic response under those conditions. Co-immunoprecipitation assays from muscle extracts indicated that E2F1 and pRB were associated in the same protein complex (Supplementary Fig. S5a ). As this is known as a repressor complex, we then reasoned that cold or fasting conditions in BAT and muscle trigger pRB phosphorylation and release the pRB-E2F1 repressor complex. This was supported by our results showing enhanced levels of pRB phosphorylation in BAT of mice placed at 4
• C for 4 h, as well as in muscle of mice fasted for 24 h (Fig. 3c,d and Supplementary Fig. S5b,c) . Interestingly, treatment of mice with isoprotenerol, which is a β3-adrenergic receptor agonist that mimics fasting conditions, also resulted in pRB phosphorylation ( Fig. 3e and Supplementary Fig. S5d ). The level of mitochondrial activity was increased in the presence of isoprotenerol, which indicated that the cyclin-dependent kinase 4 (CDK4)-pRB-E2F1 pathway mediated the effects of isoprotenerol. Consistent with this hypothesis was the observation that CDK4 inhibition results in the abrogation of the increased mitochondrial activity by isoprotenerol (Fig. 3f) . Moreover, we found that E2F1 directly bound to the promoters of several genes implicated in oxidative metabolism (Fig. 3g-i and Supplementary  Fig. S5e ). Under basal temperature and nutrient availability, which elicit low oxidative activity, E2F1 was associated with pRB on the promoters of most of the studied genes in BAT and muscle ( Fig. 3g-i) . Consistent with pRB phosphorylation status, when oxidative metabolism was triggered by cold or fasting conditions, pRB was released from E2F1, which enabled transcription (Fig. 3a,b) . Furthermore, on return to basal conditions, the level of acetylated histone H4, an epigenetic marker of transcription, was decreased, indicating a reduction in the level of transcription( Supplementary Fig. S5f,g ).
To further prove our hypothesis of the pRB-dependent regulation of gene expression during the adaptive metabolic responses, we analysed mice expressing a mutant CDK4 that cannot bind the cell-cycle inhibitor p16Ink4a (CDK4 R24C/R24C ). This mutation renders CDK4 hyperactive and deregulated, resulting in pRB being constitutively phosphorylated and consequently dissociated from E2Fs (ref. 7) . Oxygen consumption (Fig. 4a ) and running endurance (Fig. 4b) were
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IgG pRB Immunoprecipitates (IP) were analysed by qPCR (g,i) or classical PCR (h) with specific primers for the E2F-responsive element identified in these promoters (see Supplementary Table S1 for sequences). Values represent means ± s.e.m. * P < 0.05; * * P < 0.01; * * * P < 0.001.
refed versus E2f1 −/− refed. Uncropped images of blots are shown in Supplementary Fig. S7 .
increased in the CDK4
R24C/R24C background. Moreover, mRNA levels of oxidative genes were modulated during fasting in wild-type mice, whereas their expression levels were increased independently of feeding or fasting conditions (Fig. 4c) . Interestingly, pRB was recruited on E2F1 target genes in the muscles of wild-type mice in the fed state, whereas pRB was not found in these promoters in any condition tested in muscles of CDK4 R24C/R24C mice (Fig. 4d ). The phenotype of the double mutant E2f1 −/− and CDK4 R24C/R24C mice was not different from the E2f1 −/− mice, further indicating that E2F1 mediates the observed effects in the CDK4 R24C mice (data not shown). These results demonstrated first, that CDK4 is a major regulator of E2F1 activity in the context of metabolic control through phosphorylation of pRB; and second, that E2F1 mediated the adaptive oxidative metabolic responses to cold and fasting.
The effects of E2F1 were cell autonomous, because E2f1
primary myoblasts also showed increased mitochondrial activity ( Supplementary Fig. S6a ) and increased oxidative metabolic gene expression ( Supplementary Fig. S6b ). Interestingly, E2f1 −/− and E2f1 +/+ myoblasts showed a similar efficiency for differentiating into myotubes (Supplementary Fig. S6c ). This indicated that E2F1 was not required for myoblast proliferation or differentiation in vitro. Importantly, mitochondrial activity in E2f1 −/− differentiated myofibres ( Supplementary Fig. S6d) R24C/R24C mice were tested for physical endurance. Average running time to exhaustion is shown. n = 6 animals per group. (c) qPCR quantification of the expression of relevant genes involved in oxidative metabolism in GNM of wild-type versus CDK4 R24C/R24C mice in fasted/refed conditions. Results were normalized to the expression of mouse 18S RNA and are expressed as means ± s.e.m. of three independent experiments. n = 3 animals per group. (d) ChIP demonstrates binding of E2F1 and pRB to oxidative metabolic gene promoters in muscle in 24 h fasting and 5 h refed conditions. n = 3 animals. Values represent means ± s.e.m. * P < 0.05; * * P < 0.01; † P < 0. Fig. S6f,g ). Accordingly, the transcriptional program of differentiated E2f1 −/− myotubes was directed towards oxidative metabolism ( Supplementary Fig. S6h ), and their glycolytic gene expression level was decreased when compared with E2f1 +/+ myotubes ( Supplementary Fig. S6i ). When compared with myotubes, mRNA levels of only 4 out of 18 glycolytic genes were decreased in the GNMs of E2f1 −/− mice ( Supplementary Fig. S6j ). These results support our data in adult muscles, although it should be interpreted with caution because these cells have features of stem cells. A decrease in serum lactate levels was observed ( Supplementary Fig. S6k ), indicating a role for E2F1 in the control of the glycolytic pathway in mice.
E2Fs function as activators or repressors of transcription 8 . E2F1 proteins have demonstrated paradoxical functions in the control of cell proliferation and apoptosis 9 , which may be dictated by promoter sequence and/or promoter context 10 . As Dhfr and Tk1 mRNA levels were not changed in muscle of E2f1 −/− mice, nor on fasting/refeeding conditions (Fig. 5a) , we investigated the molecular mechanisms underlying the differential regulation of proliferative versus metabolic E2F1 target genes. The level of E2F1 recruitment was not significantly increased on proliferative promoters when compared to IgG, as evidenced by chromatin immunoprecipitation (ChIP) assays (Fig. 5b) . Computational analysis of Dhfr and Tk1 promoters revealed the presence of CpG islands in genomic regions known to interact with E2F1. Most importantly, we demonstrated that these DNA sequences were methylated in wild-type muscle. This epigenetic modification blocks E2F1-mediated gene transactivation of these proliferative genes (Fig. 5c) . Conversely, the Ppargc1a promoter was not methylated in muscle, as evidenced by the absence of PCR amplification of this promoter region (Fig. 5c) . Taken together, these data demonstrated that the differential regulation of proliferative versus metabolic genes in muscle is operating, at least in part, through CpG island methylation of E2F1 responsive elements. transcriptional activity through the release of pRB, which induces the cell to switch to oxidative metabolism. This molecular mechanism enables the transcription of an oxidative metabolic gene programme, allowing the cell to adapt to energy demands and triggers physiological processes such as thermogenesis in BAT or enhanced physical activity in muscle. On the other hand, classical proliferative E2F1 target genes are not subjected to E2F1 regulation because of epigenetic mechanisms. Uncropped images of blots are shown in Supplementary Fig. S7 .
The physiological implications of our findings are not limited to the control of oxidative metabolism, but also concern the relationship between cell growth, proliferation and function. The E2F1-pRB repressor complex translates signals that sense the metabolic needs of the cell into a transcriptional response. Usually, when biosynthetic processes are required, such as when the rate of cell division is increased, cells switch to glycolytic metabolism, and decrease the level of oxidative phosphorylation. We showed that E2F1 orchestrates a complex control of oxidative and glycolytic metabolisms, necessary for cell proliferation and adaptations to energy demands notably during fasting, and cold ( Supplementary Fig. S5d ). E2f1 −/− mice had increased levels of mitochondrial activity under normal conditions in glycolytic muscle and BAT. Genetic inactivation of E2f1 released the inhibition of oxidative pathway genes implicated in mitochondrial function and biogenesis required to provide energy to the cell to overcome the lack of nutrients, and to generate heat to fight cold temperature 11 . Skeletal muscle adapts to different physiopathological conditions by changing its physical, contractile and metabolic properties to accommodate alterations in functional demands 12 . Thus, slow (type I) fibres, rich in mitochondria, typically work under oxidative conditions; fast (type II) fibres, with fewer mitochondria, typically work under anaerobic conditions 13 . Regulation of fibre-type determination in skeletal muscle is still not well understood, especially at the transcriptional level, although some studies demonstrated the key participation in the switch to oxidative muscles fibres of the nuclear receptor PPARδ (ref. 14), the transcription factor NFAT (ref. 15) or the transcriptional co-regulators PGC-1α and RIP-140 (refs 16,17) . We showed that E2F1 is also one of such transcriptional modulators of the metabolic oxidative response. When compared with other factors, E2F1 is unique because it can coordinate both a metabolic and proliferative response. In this study we show that E2F1 silenced oxidative metabolic gene expression and increased the level of glycolytic gene expression. This is consistent with the observed correlation of increased E2F1 activity with abnormal mitochondrial respiration and function in highly proliferative cancer cells 18 . Recent studies have shown that, in dividing cells, E2Fs function as transcriptional activators, but in differentiating cells, E2F-pRB complexes repress transcription 19 . Here, we showed that the E2F1 formed a complex with pRB to modulate oxidative gene expression. This is consistent with recent results that indicated that adipose-tissue-specific pRb−/− mice had a strong metabolic phenotype, markedly similar to E2f1 −/− mice 20 . Muscle adaptation to nutrient availability, cold conditions or exercise requires signalling pathways that will ultimately activate E2F1 transcriptional activity. In line with this hypothesis, we observed increased levels of phosphorylation of pRB during these processes. However, the pathways regulating the CDK4-E2F1-pRB complexes in muscles were still unknown. We showed here that catecholamines, whose secretion is increased during fasting/cold conditions, play a role in activating cyclin D-CDK4 complexes.
Our results, showing that E2F1 and pRB complexes repress oxidative metabolism, underscore an important role for E2F1 in the control of mitochondrial metabolism.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology
Note: Supplementary Information is available on the Nature Cell Biology website
METHODS
Materials and oligonucleotides.
Chemicals, unless stated otherwise, were purchased from Sigma. PD0332991 was purchased from Euromedex. Anti-E2F1 (C-20 and KH-95) and anti-pRB (C-15) antibodies were from Santa Cruz Biotechnology. Anti-acetylated H4 (Lys 12) and anti-Ser-780-phospho-pRB were from Cell Signaling. Anti-MyHC-I (BA-F8), IIa (SC-71) and IIb (BF-F3) were purchased from the Developmental Studies Hybridoma Antibody Core at the University of Iowa. Oligonucleotide sequences are given in Supplementary Table S1 .
Animal experiments. E2f1 +/+ and E2f1 −/− mice were purchased from the Jackson Laboratory. CDK4 R24C/R24C mice were described previously 7 . Mice were maintained according to European Union guidelines for use of laboratory animals. In vivo experiments were carried out in compliance with the French guidelines for studies on experimental animals (Animal House agreement no. B-34-172-27, Authorization for Animal Experimentation no. 34.324). All experiments were performed with male mice. Energy expenditure was measured with Oxymax apparatus (Columbus Instruments). The cold test was carried out on animals individually housed at 4 • C for 4 h as described previously 20 . Endurance was tested in 2-h-fasted mice with a treadmill equipped with an electrical shock grid (Bioseb) 21 . Briefly, animals were acclimatized to the test using a habituation protocol one day before the test consisting of a run at 27 cm s −1 for 10 min. The endurance test was carried out on 2-h-fasted weight-matched E2f1 +/+ and E2f1 −/− mice at an initial speed of 18 cm s −1 for 10 min. The speed was progressively increased (around 4 cm s −1 each 10 min) to reach the maximal speed of 38 cm s −1 at the end of the running test. The distance run and the number of shocks were recorded throughout the test and a mouse was considered exhausted and removed from the experiment when it received 180 shocks. For intramuscular (i.m.) electrotransfer, mice were randomized and anaesthetized by intraperitoneal (i.p.) injection of a ketamine (30 mg kg −1 ) and xylazine (10 mg kg −1 ) solution. The paws were shaved, and 70 µg of pCMV expressing E2F1 or empty plasmid was injected i.m. in 70 µl into the GNM of E2f1 +/+ and E2f1 −/− mice. For in vivo silencing experiments, 50 µg of pRNATU6 (control), or pRNATU6 expressing shRNA against Ucp2, Ppargc1a, Esrra or Pdk4 was injected i.m. into the GNM. Following i.m. injections, echographic gel was applied and transcutaneous electric pulses were applied using two custom-made stainless-steel plate electrodes placed on either side of the hind limb as described previously 22 . Experiments were carried out four days after electroporation, except if stated otherwise. For fasting/refeeding experiments, mice were fasted for 24 h or fasted for 20 h and refed 4 h before collecting tissues. For cold experiments, mice were maintained at 23 • C or placed at 4 • C for 4 h and fasted during the time of the experiment. For isoproterenol treatment, mice were fasted for 4 h and treated for 30 min by i.p. injection of isoproterenol at a dose of 10 mg kg −1 body weight.
Ultrastructural evaluation. GNM and BAT were immersed in a solution of 3.5% glutaraldehyde in phosphate buffer (0.1 M, pH 7.4) overnight at 4 • C, subsequently rinsed in phosphate buffer and post-fixed in 1% osmic plus 0.8% potassium ferrocianide for 2 h in the dark at room temperature. After two rinses in a phosphate buffer, tissues were dehydrated in a graded series of ethanol solutions (30-100%) and then embedded in EmBed 812 DER 736. Thin sections (85 nm ; Leica-Reichert Ultracut E) were collected at different levels of each block. These sections were counterstained with uranyl acetate and lead citrate and observed using a Hitachi 7100 transmission electron microscope in the Centre de Ressources en Imagerie Cellulaire de Montpellier (France).
Oxygen consumption. Measurements of oxygen consumption were carried out in liver, muscle and BAT isolated mitochondria or myoblasts, myotubes and MEFs permeabilized with 100 µg ml −1 of digitonin. Briefly, tissues were homogenized into isolation buffer (250 mM mannitol, 10 mM EDTA, 45 mM Tris-HCl, 5 mM Tris base at pH 7.4) using a Dounce homogenizer. Nuclei and cell debris were removed by centrifugation at 326g for 10 min. Mitochondria were isolated from supernatant by spinning twice at 326g for 10 min. The mitochondrial pellet was resuspended in isolation buffer and kept on ice. Mitochondrial protein was measured by the Bradford method (BioRad). The rate of mitochondrial oxygen consumption was measured at 37 • C in an incubation chamber with a Clark-type O 2 electrode, as described in ref. 21 (Strathkelvin Instruments), filled with 1 ml of respiration medium (15 mM KCl, 30 mM KH 2 PO 4 , 25 mM Tris base, 45 mM sucrose, 12 mM mannitol, 5 mM MgCl 2 , EDTA 7 mM, 20 mM glucose and 0.2% BSA). Cells were collected by trypsinization and washed twice in respiration medium (0.25 M sucrose, 20 mM HEPES at pH 7.1 and 10 mM MgCl 2 for MEFs; PBS, 35 mM HEPES, 5.55 mM glucose and 1% BSA for myoblasts and myotubes). Cell pellets were kept on ice. Before the addition of the cells in the chamber, the medium was supplemented with 2 mM KH 2 PO 4 , 5 mM malate and 100 µg ml −1 digitonin. Concentrated cells were added to 1 ml of respiration medium. All measurements were carried out using mitochondria (3 mg ml −1 ) or MEFs (3 million cells), myoblasts (4 million cells) and myotubes (1 million cells) incubated with succinate (5 mM) as a substrate, in the presence or absence of 1 mM ADP. The incubation medium was constantly stirred with a magnetic stirrer. Respiration values were normalized to mitochondrial protein content for tissues or cell number for MEFs, myoblasts and myotubes.
Mitochondrial DNA quantification, RNA extraction, RT-PCR and qRT-PCR. For DNA extraction, tissues were digested in a lysis buffer containing proteinase K and 10% Chelex 100 resin (BioRad). Quantitative PCR (qPCR) was carried out on DNA diluted 200 times using mitochondrial-(ND2) and nuclear-(28S) specific primers. For gene expression analysis, total RNA extraction from E2f1 +/+ and E2f1 −/− tissues and primary MEFs, myoblasts and myotubes and PCR with reverse transcription (RT-PCR) were carried out as described previously 6, 23 . qPCR was carried out using a LightCycler 480 and the DNA-double-strand-specific Power SYBR Green master mix for detection (Applied Biosystems). qPCR was carried out using gene-specific oligonucleotides and results were then normalized to 18S levels (Supplementary Table S1 ).
Histology, immunofluorescence microscopy, biochemical analysis and MitoTracker staining. Haematoxylin staining, immunohistochemistry (phosphopRB, 1:50) and immunofluorescence microscopy (MyHC, 2 µg per section; E2F1, 1:50) analyses were carried out on 5 µm formalin-fixed paraffin-embedded tissue sections and succinate dehydrogenase activity was measured using 10 µm frozen sections as described previously 24, 25 . Citrate synthase activity was determined on GNM homogenates as described previously 21, 26 . Serum lactate levels were measured at the Service Phenotypage de l'IFR 150 (Toulouse, France) on mice fasted for 16 h. For MitoTracker staining, primary MEFs were cultured on coverslips overnight and then incubated for 30 min with 100 nM MitoTracker red CMXROS (Molecular Probes). Cells were subsequently rinsed with PBS and fixed with 3.7% formaldehyde, for 15 min. After washing, cells were mounted with fluorescent medium (Dako) and observed under a fluorescence microscope (Leica Microsystemes SAS).
Protein extracts, co-immunoprecipitation and immunoblot analysis. Protein extracts and sodium dodecyl sulphate (SDS)-polyacrylamide gel electrophoresis (PAGE), electrotransfer and immunoblotting were carried out as described previously 27 . Co-immunoprecipitation experiments were described elsewhere 5 . Antibody dilutions were 1:50,000 for MHC, 1:5,000 for tubulin, 1:5,000 for actin, 1:1,000 for pRB and 1:500 for E2F1.
Cell culture and shRNA experiments. Primary E2f1 +/+ and E2f1 −/− MEFs were obtained from embryos at embryonic day 13.5 by standard methods. Primary pRb −/− MEFs were described elsewhere 28 . Monolayer cell cultures were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 25 mM glucose and 10% fetal calf serum (FCS; Invitrogen). In vitro shRNA experiments were carried out by retroviral infection. Phoenix cells were transfected with either pSUPERretro (Oligoengine), or pSUPERretro expressing shRNA against Tfam (5 -GTGTGAAACGATCCGGAGA-3 ), Cpt-1 (5 -GAAGTTCATCCGATTCAAG-3 ) or Ucp2 (5 -GCCTACAAGACCATTGCAC-3 ), or pSUPER expressing shRNA against Ppargc1a (5 -CAGCCGAGGACACGAGGAA-3 ), Esrra (5 -GCTGTACGCCATG-CCTGAC-3 ) or Pdk4 (5 -GCCACATTGGAAGTATCGA-3 ) using JetPEI (Invitrogen). After 48 h of transfection, the medium containing retroviruses was collected, filtered, treated with Polybrene (1 µg ml −1 ) and transferred to MEF target cells. At 48 h after transfection, cells were collected and processed for oxygen consumption analysis. For in vivo experiments, shRNA oligonucleotides were cloned in pRNAT-U6 vector, and electroporated in GNM of E2f1 +/+ and E2f1 −/− mice mice. Downregulation was verified by qPCR analysis, and 4 out of 6 shRNA were validated.
Primary muscle cell cultures were derived from GNM and tibialis anterior muscles of three 1-week-old mice, as described previously 29 . Briefly, muscles were partly digested with four sequential 10 min incubations in DMEM/HamF12 medium containing 0.14% pronase (Gibco). The supernatants from the second, third and fourth digestions were pooled and filtered through a 100-µm cell strainer. Cells were centrifuged, washed twice, counted and plated at a low density (100 cells cm −2 ) on 12-well plates coated with gelatin (type A from pig skin; Sigma). Myoblasts were grown in complete medium (DMEM/Ham F12, 2% Ultroser G, 20% fetal calf serum, penicillin, streptomycin and l-glutamine) on gelatine-coated plates. After one week, wells containing myoblasts without contaminating fibroblasts were trypsinized, pooled and expanded. Experiments were carried out on cells kept in culture for not more than one month (6-15 passages). Complete medium was changed every two days, and cultures were trypsinized before subconfluence to avoid differentiation. To differentiate muscle cells, myoblasts were plated on Matrigel-coated dishes at 30,000 cells cm −2 in DMEM/Ham F12 containing 2% horse serum.
ChIP. ChIP assays were carried out as described previously 5, 30 on mice subjected to 4 h at room temperature versus 4 • C (for BAT) or 24 h fasted versus 20 h fasted and then 4 h refed. Briefly, proteins from BAT and muscle tissues were formaldehyde crosslinked to DNA. After homogenization, lysis and DNA
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sonication, proteins were then immunoprecipitated using purified IgGs, anti-E2F1, anti-pRB or anti-acetylated H4 antibodies. After washing, DNA-protein complexes were subsequently eluted and crosslinking was reversed by heating the samples at 65 • C for 16 h. DNA was then purified using a Qiagen PCR purification kit (Qiagen) and qPCR was carried out using promoter-specific primers (Supplementary Table  S1 ). As a negative control, tissues from E2f1 −/− mice were used and qPCR analysis demonstrated no binding of E2F1 on its target genes.
DNA methylation analysis. The methylation status of Dhfr and Tk1 promoters was analysed in silico using http://www.urogene.org/methprimer/ and in vivo on isolated genomic DNA using the MethylCollector kit (Active Motif) following the manufacturer's instructions. Briefly, DNA was extracted from GNM using a DNeasy Blood and Tissue Kit (Qiagen). A quantity of 4 µg of DNA was digested for 2 h at 37 • C by MseI and incubated with purified methyl-CpG binding domain 2b (MBD2b) proteins. DNA-protein complexes were captured using magnetic beads and DNA was recovered after washing and elution. The methylation status of the promoter was subsequently analysed by PCR using promoter-specific primers. 
